ScholarIQanswers from OpenAlex

Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters

PaperCitations, authors & open-access status

Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters have?

ScholarIQcitation count

Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters has 21 citations in the OpenAlex counts ScholarIQ stores.

When was Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters published?

ScholarIQyear

Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters has 2019 year in the ScholarIQ index.

What is the open-access status of Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters?

ScholarIQoa status

Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters has gold oa status in the ScholarIQ index.

What is the DOI of Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters?

ScholarIQdoi

The DOI for Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters is on the source record.

What is the PMID of Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters?

ScholarIQpmid

The PMID for Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters is on the source record.

What is the OpenAlex record for Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters?

ScholarIQopenalex

The OpenAlex for Protein-activated transformation of silver nanoparticles into blue and red-emitting nanoclusters is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial